Effector Therapeutics   Report issue

For profit Phase 1 Phase 2
Founded: San Diego CA United States (2012)

Organization Overview

First Clinical Trial
2015
NCT02605083
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Effector Therapeutics | eFFECTOR Therapeutics, Inc. | eFFECTOR Therapuetics